<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04568941</url>
  </required_header>
  <id_info>
    <org_study_id>ShandongCHI-13</org_study_id>
    <nct_id>NCT04568941</nct_id>
  </id_info>
  <brief_title>Comparison Study of Different Tumor Biopsy Method for Sentinel Lymph Node Biopsy in Breast Cancer</brief_title>
  <official_title>Randomized Controlled Trial of Comparison of Tumor Biopsy Method of Preoperative Vacuum-Assisted, Core Needle Versus Intraoperative Excisional Biopsy for Sentinel Lymph Node Biopsy in Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shandong Cancer Hospital and Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shandong Cancer Hospital and Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sentinel lymph node biopsy (SLNB) has become a mainstay surgery method in breast cance, and&#xD;
      the identified number of sentinel lymph nodes determines its accuracy for axillary status.&#xD;
      Retrospective study indicated that preoperative tumor biopsy results in more detected&#xD;
      sentinel lymoh nodes. The clinical trail is designed to compare the effect of three tumor&#xD;
      biopsy methods (preoperative vacuum-assisted biopsy, core needle biopsy, and intraoperative&#xD;
      excisional biopsy) for sentinel lymph nodes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
      Compare the identification rate of sentinel lymph node in breast cancer patients with&#xD;
      different tumor biopsy methods.&#xD;
&#xD;
      Evaluate the false-negative rates of sentinel lymph nodes in patients with different tumor&#xD;
      biopsy methods.&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      The patients were randomly divided into three group, vacuum-assisted biopsy, core needle&#xD;
      biopsy, and intraoperative excisional biopsy. Preoperative vacuum-assisted biopsy and core&#xD;
      needle biopsy were performed in 10 days before the final surgery. All patients received dual&#xD;
      tracer (radiolabeled colloid and blue dye) guided SLNB.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Identification rates of sentinel lymph node biopsy</measure>
    <time_frame>1 year</time_frame>
    <description>Identification rate of SLNB between three groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identification numbers of sentinel lymph node biopsy</measure>
    <time_frame>1 year</time_frame>
    <description>Identification numbers of SLNB between three groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fase-negative rates of sentinel lymph node biopsy</measure>
    <time_frame>1 year</time_frame>
    <description>fase-negative rates of SLNB between three groups</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Sentinel Lymph Node</condition>
  <arm_group>
    <arm_group_label>Preoperative Vacuum-Assisted Biopsy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Preoperative vacuum-assisted biopsy was performed within 10 days before final surgery. The tumor were excised almost.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preoperative Core Needle Biopsy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Preoperative core needle biopsy was performed within 10 days before final surgery. The needle biopsy were performed with 3 needles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intraoperative Excisional Biopsy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The tumor was excised intraoperatively.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Vacuum-Assisted Biopsy</intervention_name>
    <description>Vacuum-Assisted Biopsy</description>
    <arm_group_label>Preoperative Vacuum-Assisted Biopsy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Core Needle Biopsy</intervention_name>
    <description>Core Needle Biopsy</description>
    <arm_group_label>Preoperative Core Needle Biopsy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Intraoperative Excisional Biopsy</intervention_name>
    <description>Intraoperative Excisional Biopsy</description>
    <arm_group_label>Intraoperative Excisional Biopsy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  clinically lymph node negative breast cancer patients T1-T3&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of breast cancer locally advanced breast cancer and metastatic breast cancer&#xD;
             proven axillary lymph node metastasis history of axillary excisional or incisional&#xD;
             biopsy, or dissection history of neoadjuvant chemotherapy pregnancy non-consented&#xD;
             patients&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Zhiyong Yu, PhD</last_name>
    <phone>86-13355312277</phone>
    <email>drzhiyongyu@aliyun.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chao Li, MD</last_name>
    <phone>86-15665851082</phone>
    <email>lichao19890305@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhiyong Yu</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Zhiyong Yu, PhD</last_name>
      <phone>86053167626958</phone>
      <phone_ext>86053167626958</phone_ext>
      <email>drzhiyongyu@aliyun.com</email>
    </contact>
    <contact_backup>
      <last_name>Chao Li, MD</last_name>
      <phone>86053167626958</phone>
      <phone_ext>86053167626958</phone_ext>
      <email>lichao19890305@126.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/32693797/</url>
    <description>Related Info</description>
  </link>
  <results_reference>
    <citation>Yuan C, Wang X, Liu Z, Li C, Bian M, Shan J, Song X, Yu Z, Yu J. Preoperative tumor biopsy results in more detected sentinel nodes than intraoperative biopsy in breast cancer patients. World J Surg Oncol. 2020 Jul 21;18(1):178. doi: 10.1186/s12957-020-01942-4.</citation>
    <PMID>32693797</PMID>
  </results_reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 26, 2020</study_first_submitted>
  <study_first_submitted_qc>September 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 29, 2020</study_first_posted>
  <last_update_submitted>October 24, 2020</last_update_submitted>
  <last_update_submitted_qc>October 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shandong Cancer Hospital and Institute</investigator_affiliation>
    <investigator_full_name>Zhiyong Yu</investigator_full_name>
    <investigator_title>Zhiyong Yu</investigator_title>
  </responsible_party>
  <keyword>Sentinel Lymph Node</keyword>
  <keyword>vacuum-assisted biopsy</keyword>
  <keyword>Core needle biopsy</keyword>
  <keyword>Breast Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

